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Remodeling of retrotransposon 
elements during epigenetic induction of adult 
visual cortical plasticity by HDAC inhibitors
Andreas Lennartsson1,8†, Erik Arner2†, Michela Fagiolini3,4, Alka Saxena2, Robin Andersson5, Hazuki Takahashi2, 
Yukihiko Noro2, Judy Sng3,4,6, Albin Sandelin5, Takao K. Hensch3,4,7* and Piero Carninci2*
Abstract 
Background: The capacity for plasticity in the adult brain is limited by the anatomical traces laid down during early 
postnatal life. Removing certain molecular brakes, such as histone deacetylases (HDACs), has proven to be effective 
in recapitulating juvenile plasticity in the mature visual cortex (V1). We investigated the chromatin structure and 
transcriptional control by genome-wide sequencing of DNase I hypersensitive sites (DHSS) and cap analysis of gene 
expression (CAGE) libraries after HDAC inhibition by valproic acid (VPA) in adult V1.
Results: We found that VPA reliably reactivates the critical period plasticity and induces a dramatic change of chro-
matin organization in V1 yielding significantly greater accessibility distant from promoters, including at enhancer 
regions. VPA also induces nucleosome eviction specifically from retrotransposon (in particular SINE) elements. The 
transiently accessible SINE elements overlap with transcription factor-binding sites of the Fox family. Mapping of 
transcription start site activity using CAGE revealed transcription of epigenetic and neural plasticity-regulating genes 
following VPA treatment, which may help to re-program the genomic landscape and reactivate plasticity in the adult 
cortex.
Conclusions: Treatment with HDAC inhibitors increases accessibility to enhancers and repetitive elements underly-
ing brain-specific gene expression and reactivation of visual cortical plasticity.
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Background
Patterns of neural activity shape the circuits that pro-
cess sensory information during early windows of brain 
development [1]. Such critical periods of plasticity have 
been identified across modalities, including tonotopic 
map refinement in auditory cortex, barrel representa-
tion of whiskers in rodent somatosensory cortex, human 
language acquisition in Broca’s area and spatial acuity 
in the developing visual system [1–3]. Increased insight 
into how critical periods are regulated offers the poten-
tial to develop novel therapies for various neurological 
disorders or brain damage later in life. Recently, spe-
cific molecular players have been identified which con-
trol critical period timing in the visual cortex [1, 4, 5, 6]. 
While the rewiring capacity of the adult brain is known 
to be rather limited, the removal of certain molecular 
‘brakes’ can be effective in recapitulating juvenile plastic-
ity [7, 8].
Chromatin modulating factors in particular have been 
suggested to function as plasticity regulators. The class 
I histone deacetylase, HDAC2 inhibits memory forma-
tion and synaptic plasticity in the hippocampus [9], and 
the class II HDAC, HDAC5 is shown to be involved in 
depression [10]. Additionally, epigenetic mechanisms 
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contribute to plasticity regulation and memory in the 
aging hippocampus [11]. Notably, acute pharmacologi-
cal manipulation with HDAC inhibitors (HDACi) such 
as valproic acid (VPA) or trichostatin A (TSA) has been 
found to enable juvenile forms of cortical plasticity in 
adult rodents [12–14] and humans acquiring absolute 
pitch [15].
Classically acting as a potent inhibitor of GABA clear-
ance, VPA has been a first-line drug treatment for epi-
lepsy and manic disorder. More recently, VPA has been 
shown to be an HDACi as effective as, sodium butyrate, 
to induce epigenetic changes that promote recovery of 
visual acuity [13]. Indeed, its capacity as an HDACi has 
produced very promising therapeutic results in clinical 
trials for cancer, inflammatory diseases and central nerv-
ous system disorders [16–18]. At the same time, reopen-
ing of plastic brain states during cancer treatment may 
yield unwanted side effects [19]. A deeper mechanistic 
understanding is warranted whether HDAC inhibition by 
VPA induces local site-specific or genome-wide chroma-
tin structure modulations in the brain.
Here, we show how HDAC inhibition by VPA influ-
ences chromatin structure and transcriptional control 
at a genome-wide level in a complex tissue such as the 
adult neocortex. We analyzed changes in genome-wide 
DNase I hypersensitivity sites (DHSS) of the visual cor-
tex after either VPA or vehicle (Veh) treatment. Genome-
wide studies of DHSS have been successfully performed 
in cell lines and primary suspension cells to accurately 
map regulatory regions in the genome [20–23]. In this 
study, we used DNase I to digest accessible DNA that is 
not protected by nucleosomes and compact chroma-
tin formation. This yields the DHSS that correspond to 
nucleosome-free regions (NFR) and signature accessi-
ble regulatory regions, such as transcription start sites 
(TSSs), promoters, enhancers, silencers, insulators and 
locus control regions [21–25]. To understand transcrip-
tional control, we constructed and sequenced cap analy-
sis of gene expression (CAGE) libraries which precisely 
map the TSS location and estimate mRNA levels from 
VPA- and Veh-treated mice [26–29]. CAGE technology 
captures the cap structure in the 5′-end of mRNAs before 
they are processed and sequenced, resulting in genome-
wide 5′-end transcript signatures to obtain precise TSS 
corresponding to the expression levels [30, 31]. We iden-
tified potential novel plasticity regulatory mechanisms, 
involving increased accessibility of enhancers, retro-
transposon elements and in particular, short interspersed 
nuclear elements (SINEs). These elements were found to 
overlap significantly with computationally determined 
Forkhead box (Fox)-binding sites. Interestingly, VPA 
treatment induces the transcription of chromatin and 
neural plasticity regulatory genes, including Foxg1.
Results
Valproic acid reinstates ocular dominance plasticity 
and improves visual acuity in the adult visual cortex
Occluding one eye during the critical period (CP) (but 
not in adulthood) results in a shift of cortical spiking 
response (ocular dominance) in favor of the open eye 
and an enduring blunted vision (amblyopia) through the 
deprived eye [1]. A preliminary study with TSA in adult 
rats reported a reduced amplitude visual-evoked poten-
tial (VEP) upon deprivation [12] and the same group 
showed that VPA restores behavioral acuity to normal 
levels in adult rats previously deprived through that eye 
[13]. However, whether such reopened plasticity reflects 
changes in the spiking activity of single neurons within 
primary visual cortex remains unknown.
We administered VPA (200 mg/kg, i.p. every 12 h) for 
2  days prior to and concomitant with monocular dep-
rivation (>4  days) of adult C57Bl/6J mice (P60) then 
performed single-unit electrophysiological recordings 
in  vivo. Strikingly, VPA acutely restored a full ocular 
dominance shift comparable to that observed normally 
during a CP. Spiking activity in the mouse visual system 
is naturally skewed toward the contralateral eye, which is 
unaltered by sensory deprivation at this age (Fig. 1a, vehi-
cle, upper panel, white bars). Monocular deprivation in 
the presence of VPA instead induced a shift toward the 
open-eye input as rated on a seven-point scale of neu-
ronal responsiveness (Fig.  1b, VPA, lower panel, black 
bars).
The contralateral bias index (CBI) of individual animals 
captures the robustness of VPA-induced adult plastic-
ity (Fig.  1c, VPA, closed circles). Since VPA is a known 
GABA transaminase inhibitor that would enhance 
endogenous inhibitory tone [33], we also tested whether 
directly enhancing GABA signaling with benzodiaz-
epines might reopen adult plasticity (Fig. 1c, DZ, closed 
triangles). As expected [34], further strengthening inhibi-
tion after the CP produced no reduction of CBI, whereas 
VPA was totally effective. Moreover, HDAC activity in 
visual cortex was reduced by greater than 30 %, identical 
to Trichostatin A (TSA just 2 h after systemic injection of 
VPA (Fig. 1d).
Taken together, we confirmed the induction of a sec-
ond period of plasticity in the adult mouse visual cortex 
by VPA (Fig. 1e), which is likely to reflect its action as an 
HDACi rather than a dampening of excitability.
DHSSs in visual cortex are enriched in TSSs
To obtain a comprehensive view of how VPA treatment 
might change chromatin structure, we constructed DHSS 
libraries from VPA- (200 mg/kg, i.p.) and vehicle (saline)-
injected mice. Libraries were prepared 120 min after sin-
gle injection, consistent with a recent report that HDACi 
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induces a transient increase of histone acetylation (75–
150 min after injection) in brain tissues [35].
TSSs have previously been shown to be nucleosome 
free and correspond to DHSSs [22, 25, 36]. As expected, 
DHSS correlated better with highly expressed TSSs than 
those with low expression (Additional file 1: Figure S1a, 
b), reflecting that transcription levels associate with 
accessible promoter regions. Furthermore, there was a 
marked difference in enrichment between promoters 
with a well-defined (single peak) TSSs and promoters 
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Fig. 1 VPA reinstates ocular dominance plasticity in adult visual cortex. a The mouse visual system is naturally skewed toward the contralateral eye. 
Unlike during the CP [32], brief monocular deprivation (4d MD) fails to alter this ocular dominance of V1 neurons rated on a seven-point scale (white 
bars). b Upon VPA administration (6d) prior to and concurrent with adult MD, responsiveness once again can shift in favor of the open eye (black 
bars; n = 98 and 103 cells from n = 4 mice per group, CBI = 0.72 and 0.51, respectively; p < 0.001, χ2 test). c Significant CBI reduction by MD occurs 
only with VPA (closed circles, p = 0.0002, unpaired two tailed t test versus vehicle, open circles). Enhancing inhibition, an alternative consequence of 
VPA treatment [33], is insufficient to induce adult plasticity, as benzodiazepine agonists (DZ, closed triangles; Veh, open triangles) fail to reduce CBI. 
d Reduction of histone deacetylase (HDAC) activity within 2 h of either valproic acid (VPA) or trichostatin A (TSA) administration. HDAC activity 
normalized to vehicle (***p = 0.0004, **p = 0.0024; unpaired two-tailed t test, n = 3 per group). e Treatment with HDACi re-activates the critical 
period in adult mice
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with multiple, widely spread (broad) TSSs, the latter 
being more highly enriched for DHSS tags (Additional 
file 1: Figure S1c, d).
Strikingly, the enrichment of DHSS tags in TSSs was 
considerably stronger in the vehicle-treated sample com-
pared to the VPA-treated sample (Fig.  2a). We hypoth-
esize that this could be either a consequence of TSSs 
becoming less accessible after VPA treatment, or more 
likely, that the treatment induces a general increased 
genome availability occurring mainly outside of TSSs. 
The latter would lead to a diluted ratio of DHSS tags orig-
inating from TSSs in the VPA-treated sample.
VPA treatment increases DNA accessibility in regions 
distant from promoters, including enhancers
To examine the extent to which VPA treatment induced 
and/or expunged sites of accessible chromatin in visual 
cortex, we clustered the DHSS tags and investigated 
their spatial location and specificity to either condi-
tion. Using a conservative threshold, 9862 clusters 
were identified (Additional file  2: Table  S1), contain-
ing tags from VPA and/or vehicle-treated mice. Further 
analysis identified 2285 clusters with a significantly 
(one-tailed Fisher’s exact test, Benjamini-Hochberg 
5 % FDR) higher number of tags from the VPA sample 
(from here on referred to as ‘VPA-induced DHSSs’). 
Conversely, only 357 clusters had a significantly higher 
number of tags from the vehicle condition. The remain-
ing 7220 clusters contained tags from both conditions 
in similar proportion (Fig. 2b). This suggested that VPA 
treatment generally added sites of genome availability, 
rather than remove them. The 7577 clusters (357 spe-
cific to the vehicle condition and 7220 not specific to 
any condition) are from here on referred to as ‘non-
induced DHSSs’.
Another set of mice in duplicate was injected with 
VPA or vehicle to confirm the DHSS libraries, and the 
appropriateness of the clustering method. The DNase 
I-digested chromatin was analyzed with a qPCR assay 
[37]. The VPA-induced DHSSs identified in the DHSS 
library, had an increased Ct value in the VPA-treated 
mice as compared to vehicle-treated mice, implying an 
enhanced sensitivity to DNase I (p value = 6.10956e−38) 
(Fig. 2c). This indicated our DHSS libraries and cluster-
ing method correctly identified true sites of accessible 
chromatin. We further designed primers at eight random 
locations outside of identified clusters. The changes in 
Ct value were approximately two- to threefold higher in 
mapped DHSSs compared to random sites (Fig. 2c). The 
fact that randomly picked locations had slightly higher 
Ct values in the VPA sample (p value =  1.1e−11) com-
pared to vehicle may reflect a general effect on chromatin 
accessibility after VPA treatment. Together, these results 
suggest that VPA treatment gives rise to an increase in 
specific, and to a lesser extent general chromatin acces-
sibility, and that our DHSS analysis identifies the chroma-
tin regions that are more open and available.
Active enhancers bi-directionally transcribe short 
RNAs that can be analyzed with CAGE. Recently, this was 
used to map active enhancers in the FANTOM5 panel 
of tissues and primary cell types [38]. As expected, the 
DHSSs overlapped significantly (p  =  8.7e−8, Binomial 
test) with enhancers (1.5 % of non-induced DHSS, 0.9 % 
of VPA-induced DHSSs). Moreover, DHSSs were found 
to be significantly closer to enhancers than expected by 
chance, p = 1.8e−5 (Kolmogorov–Smirnov test).
Further examination of the DHSS clusters dem-
onstrated that the VPA-induced DHSSs have differ-
ent characteristics compared to non-induced DHSSs. 
Genome-wide distribution of the respective DHSSs com-
pared to RefSeq gene models [39] revealed an enrich-
ment of induced DHSSs in gene bodies and not in known 
promoter regions compared to non-induced DHSS 
(Fig. 2d). Overall, these cluster analyses suggest that VPA 
treatment induces DHSSs rather than expunging them 
(Fig.  2b), and that induced regions are mainly located 
outside of TSSs (Fig. 2a, d).
VPA induces brain‑specific transcription distal to induced 
DHSSs
To dissect how the perturbed epigenetic state affects tran-
scription, CAGE was performed 2 h after VPA or vehicle 
treatment. Since the regions that were made accessible 
by VPA treatment mainly occurred outside of known 
promoter regions, we wanted to assess whether this was 
followed by transcription at novel promoters proximal to 
the induced DHSSs. Furthermore, since the induced sites 
were strongly enriched in gene bodies compared to the 
vehicle sample, another question was whether treatment 
resulted in exonic TSS [40, 41]. After sequencing and 
clustering, 9828 TSS clusters (Additional file 3: Table S2) 
were identified with 10 tpm (tags per million) or more in 
any of the two samples, out of which 1003 (14  %) were 
up-regulated in the VPA sample and 248 were downregu-
lated (one-tailed Fisher’s exact test, Benjamini-Hochberg 
5 % FDR). 6432 of the TSS clusters (65 %) were located 
in RefSeq [39] promoter regions (defined as the region 
starting 1 kb upstream of the RefSeq transcription start 
site reaching to the ATG), with the remaining 35 % con-
stituting putative novel promoters. The VPA up-regu-
lated TSS clusters (from here on referred to as ‘induced 
TSS clusters’) could be mapped to RefSeq TSS at a sig-
nificantly higher degree (79  %, p  <  2.2e−16, one-tailed 
Fisher’s exact test) than for active, but not induced TSS 
clusters (from here on referred to as ‘non-induced TSS 
clusters’) after treatment (64 %, Fig. 3a).
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DHSS tags in both induced and non-induced samples 
were enriched at TSS clusters, although with a signifi-
cantly stronger enrichment in the non-induced sample. 
Many of the TSS clusters (70 %) overlapped with previ-
ously defined deepCAGE promoters [31]. Moreover, 
induced TSS clusters overlapped previously identified 
clusters preferentially expressed in either visual or soma-
tosensory cortex to a significantly higher degree than 
non-induced TSS clusters (5.2 vs. 2.7  %, p  =  3.4e−5, 
one-tailed Fisher’s exact test, Fig.  3b). Furthermore, 
VPA-treated visual cortex demonstrated an increased 
ratio of CAGE TSS in exon 1 compared to other exons 
(p  <  2.2e−16, two-tailed t test, Fig.  3c), indicating that 
VPA resulted in reduced scattered transcription within 
genes. Despite induction of major global histone acety-
lation and putative enhanced DNA accessibility, the 
induced promoters showed high site specificity with 
regard to TSSs.
It has previously been reported that VPA treatment 
induces an epigenetic configuration that resembles a 
non-induced VPA-induced
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Fig. 2 Distribution of DHSS in VPA- or vehicle-treated visual cortex. a Average DHSS tag enrichment around CAGE promoters from a previous study 
[31] from vehicle (Veh, solid line) and VPA-treated visual cortex (dotted line). Average TPM (tags per million) are computed in 500 bp bins centered 
around the TSS. Promoters located on chrM are excluded, as are promoters containing a bin with average TPM higher than 10 times the average 
TPM for that bin across all promoters. b Venn diagram showing the distribution of DHSS tags. c Validation of DHSS by qPCR. DNase I digested DNA 
from VPA- or vehicle-treated visual cortex were amplified with primer pairs annealing within induced DHSS proximal or distal to CAGE TSS clusters, 
or randomly in the genome. Data from two biological replicates for each treatment condition is shown (VPA 1 and 2, Veh 1 and 2). Error bars are 
standard deviations. d Genomic distribution of DHSS clusters with respect to RefSeq gene models
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pre-plastic state, with high histone acetylation, which 
leads to a renewed CP in visual cortex, [12, 43]. Con-
sequently, gene ontology (GO) analysis of the induced 
genes revealed induction of several classes of GO terms, 
including “chromatin modulation” and “histone dea-
cetylase complex” (Fig.  3d). Additionally, many brain-
related processes were induced, such as learning and/or 
memory, neurogenesis, neuron development and neuron 
projection (partial list of enriched terms in Fig.  3d and 
full list Additional file  4: Table  S3), indicating that VPA 
treatment induces plasticity-related biological processes, 
which are dormant in the adult visual cortex. VPA treat-
ment induced expression of TSS clusters of 645 genes 
annotated as described above, as well as alternative TSS 
clusters in an additional 111 genes already expressed in 
untreated visual cortex (Fig. 3e). As indicated by the GO 
terms, the gene list includes epigenetic regulators, such 
as Hdac11, Hdac6, Hdac5, Fbxl11, Mbd3, Tlk1, Mll3, 
Cbx4 and Cbx6 as well as several genes implicated in 
brain development and plasticity: Arc, Egr1/2, Suds3, 
Aof2, Mta2, Syp and Magee1. Notable among these were 
the Nogo-receptor (Rtn4r) signaling pathway, which 
binds to extracellular inhibitors of neurite outgrowth, 
such as chondroitin sulfate proteoglycans (Cspg5) and 
myelin-related factors (Mbp, Rtn4) [44–46].
No association between induced DHSS and TSS was 
detected. But, investigation of the spatial distribution 
of active promoters represented by our TSS clusters, 
compared to the genomic locations of detected DHSS 
clusters, revealed that a majority of induced (89  %) as 
well as non-induced (87  %) TSS clusters were located 
between 1  kb and 1  Mb (semi-distal) from the clos-
est non-induced DHSS (Fig.  3f ). Similarly, the majority 
of TSS clusters (induced 88 %, non-induced 87 %) were 
located semi-distal to the closest induced DHSS. How-
ever, a striking difference was observed when consider-
ing DHSS proximal (within 1 kb) or distal (further than 
1 Mb) to TSS clusters. A substantial number of clusters 
(induced TSS clusters 11  %, non-induced TSS clusters 
14 %) were located proximal to the closest non-induced 
DHSSs, whereas only few TSS clusters (induced 1  %, 
non-induced 1 %) were located proximal to VPA-induced 
DHSSs. Conversely, very few promoters (induced 0.1 %, 
non-induced 0.4  %) were located distal to non-induced 
DHSSs, while a substantial number of TSS clusters 
(induced 11 %, non-induced 13 %) were located distal to 
induced DHSSs. These results suggest that non-induced 
DHSSs may be involved in proximal, positive regulation 
of non-induced as well as induced TSS clusters, whereas 
the induced DHSS may represent mainly distal regulation 
or repression.
Thus, a seemingly unspecific epigenetic perturbation 
(VPA) causes removal of nucleosomes at regions distal 
to active TSS clusters, which may be the consequence of 
a repressive effect, and induces a tissue-specific mRNA 
expression mainly from known promoter regions.
VPA‑induced DHSSs overlap with SINE and putative 
Fox‑binding sites
A detailed analysis of the genomic distribution of the 
DHSS clusters revealed that a large fraction of the induced 
DHSS overlaps with retrotransposon elements—out of 
the induced DHSS, 88 % were located in retrotransposon 
elements, compared to 67  % of the non-induced DHSS. 
Specifically, a strong enrichment in SINE elements was 
observed, with 851 induced DHSS (37  %) having their 
longest overlap with a SINE element compared to 9 % of 
non-induced DHSS (Fig. 4a). Considering all such DHSS 
(including those where a longer part of the region over-
lapped another repeat type), in total 1209 induced DHSSs 
(53 %) overlapped a SINE element. Upon further analysis 
of the induced DHSSs, SINE elements showed a specific 
over-representation in B1 elements (corresponding to 
human Alu elements) (Additional file 1: Figure S1e). The 
distribution of VPA-induced SINE DHSSs closely resem-
bled the general genomic distribution of SINE elements, 
with a minority located in promoter regions and most 
located in the gene bodies or intergenic regions (Fig. 4b). 
In contrast, non-induced SINE DHSSs had a stronger ten-
dency towards promoter regions.
(See figure on previous page.) 
Fig. 3 VPA-induced expression measured with CAGE. a Overlap between VPA-induced and non-induced TSS clusters (see main text for cluster 
definition) and RefSeq promoter regions. Promoter regions were defined as the region starting from 1 kb upstream of the RefSeq TSS and ending 
at the start of the coding region. b Overlap between VPA- and non-induced TSS clusters and previously identified CAGE promoters preferen-
tially expressed in visual or somatosensory cortex. c Distributions (box plots) of the ratio of CAGE tags mapping to the first exon in the VPA- and 
non-induced samples). Ratios were computed by dividing the number of CAGE tags mapping to the first exon with the number of tags mapping 
anywhere along the length of the whole gene (including introns) in all genes with at least 10 CAGE tags mapping to the gene. d Selected gene 
ontology terms for RefSeq genes overlapping tss clusters (overlap definition as in A). VPA-induced and non-induced TSS clusters were analyzed 
separately using GOStat [42], the full list of significant terms is listed in Additional file 4: Table S3. e Overlap between RefSeq genes overlapping TSS 
clusters according to the definition in A, and a list of selected VPA induced genes associated with brain development and chromatin regulation. The 
intersecting genes have alternative promoters that respond differentially to VPA induction. The full list of genes is listed in Additional file 3: Table S2 
along with TSS clusters. f Distributions (density plots) of the distance between VPA-induced (VPA-i) and non-induced (non-i) TSS clusters and the 
closest DHSS
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The similarity in pattern between induced DHSS 
SINE elements and the genomic SINE distribution sug-
gests that SINEs in general are not targeted by VPA 
treatment. However, further analysis revealed a strong 
deviation from general genomic SINE patterns. Scan-
ning the DHSS clusters for putative transcription 
factor-binding sites (using the TFBS toolkit [47] and 
JASPAR [48] collection of DNA-binding matrices), 
FOX family member-binding sites were identified as 
being significantly over-represented in VPA-induced 
SINEs (Fig.  4c) as compared to all other identified 
DHSS clusters.
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Fig. 4 VPA induces DHSS at retrotransposon elements. a Genomic distribution of DHSS with respect to repeat regions (defined by RepeatMasker 
[http://www.repeatmasker.org]). In cases where the same DHSS overlapped several repeats, the overlap with the greatest length was chosen. b 
Genomic distribution of SINEs overlapping non-induced (non-i) DHSS (leftmost bar), VPA-induced (VPA-i) DHSS (mid bar), and all SINEs (rightmost 
bar), with respect to RefSeq gene models. c Over-representation of forkhead motifs in induced SINE DHSS compared to all other DHSS. For each 
JASPAR forkhead motif, the number of matches (obtained using the TFBS toolkit) with at least 80 % similarity were compared between the two 
groups using one-tailed Wilcoxon rank-sum test. In all cases, p < 1.5e−16. d Overlap between SINEs and Foxa2 binding sites in mouse liver. “non-
induced (non-i)/VPA-induced (VPA-i) SINEs” indicates DHSS clusters that overlap SINEs, and “non-induced/induced n.o. SINEs” indicates clusters that 
do not overlap SINEs. “Top 50 VPA SINEs/n.o. SINEs” indicates the 50 VPA DHSS clusters with highest DHSS tag count in the VPA-i sample, which do 
or do not overlap SINEs, respectively. e Genome browser view of the 3′ end of the Hectd1 gene (NM_144788), indicating an overlap between VPA 
DHSS, SINEs and Foxa2 binding sites
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The FOX family members have a conserved DNA-
binding domain and bind to similar DNA sequences [49–
52]. Comparing our induced DHSSs to publicly available 
Foxa2-binding sites identified by ChIP-seq in mouse liver 
[53], a dramatically strong overlap was observed (Fig. 4d). 
Out of 1209 induced DHSSs overlapping with SINEs, 
391 (32  %) overlapped Foxa2 sites compared to 0.5  % 
out of the approximately 1.5 million annotated SINEs 
in the mouse genome overlapping these Foxa2 sites 
(p  <  2.2e−16, Fisher’s exact test). VPA-induced DHSSs 
not overlapping SINEs were also enriched in Foxa2-
binding sites, but to a significantly (p = 2.1e−12) lower 
degree.
Among the top 50 most sequenced induced DHSSs 
overlapping SINEs, 80  % had embedded Foxa2-binding 
sites (Fig.  4d). Non-induced DHSSs overlapping SINEs 
were also enriched for Foxa2-binding sites, but over-
lapped these sites to a substantially lower degree than 
the induced DHSSs (3 vs 1  % non-induced DHSSs not 
overlapping SINEs, Fig. 4d). We conclude that VPA treat-
ment induces a highly specific response, targeting SINE 
elements harboring forkhead box-binding sites (Fig. 4e), 
and that these proteins may play an important role in the 
VPA response.
Foxa2 is primarily expressed in liver, pancreas and lung 
[54], so consequently, no CAGE TSS clusters were pre-
sent in the Foxa2 gene from our visual cortex samples. 
However, several other forkhead proteins were expressed, 
including Foxj1 and Foxk1 in both untreated and VPA-
treated visual cortex. Instead, Foxg1 (also known as Brain 
Factor-1, BF-1) was significantly up-regulated in the VPA 
CAGE library (Additional file 5: Figure S2a). The induced 
Foxg1 TSS cluster corresponds to a novel transcript 
(BC064449) described previously [55]. The Foxg1 con-
sensus-binding site is very similar to the Foxa2-binding 
motif (Additional file 5: Figure S2b), and likely to bind to 
the same motif [56]. The up-regulation of Foxg1 was veri-
fied with qPCR (Additional file 5: Figure S2c).
Discussion
Valproic acid reinstates ocular dominance plasticity in the 
adult visual cortex
Alterations in spike output from the primary visual cor-
tex ultimately underlie the CP for visual acuity [32]. We 
first confirmed that VPA enables ocular dominance plas-
ticity at the single neuron level within the adult visual 
cortex of mice. This corroborates earlier findings in adult 
rats using local field potentials (VEP) with TSA, or whole 
animal behavior to assess acuity recovery with VPA [12, 
13, 32]. Importantly, VPA is just as potent as TSA in 
reducing HDAC activity. Other confounding actions of 
VPA, such as dampening excitability, are unlikely to have 
induced adult plasticity, since direct GABA enhancement 
with benzodiazepines at this age failed to do so (Fig. 1c). 
We, therefore, explored chromatin reorganization by 
VPA in visual cortex in detail.
VPA‑induced DHSS correspond to SINEs and Fox‑binding 
sites
Recently, the importance of retrotransposon elements 
including SINEs for brain development has been dem-
onstrated [57, 58]. Accordingly, we find that SINEs are 
correlated with CP reactivation in visual cortex and these 
have embedded Fox-binding sites (Fig.  4c, d). Fox pro-
teins bind DNA with high affinity, also when it is wrapped 
around nucleosomes, disrupting and opening up com-
pact chromatin structures with nucleosome re-arrange-
ment [51, 59, 60, 61]. FoxA1-binding does not induce 
transcription, but it has a profound effect on nucleosome 
organization and creates DHSS [62, 63]. FoxA1 has been 
shown to be recruited mainly to enhancers with only 
approximately 2  % of binding sites located at proximal 
promoters [63, 64], creating a nucleosome-free region 
while stabilizing the surrounding nucleosomes [64], and 
stable DHSS at enhancers.
Notably, FoxA1 is on the same evolutionary branch as 
FoxG1 [62], suggesting FoxG1 protein may create DHSSs 
by nucleosome remodeling in a similar manner in neu-
rons. SINEs have been shown to be over-represented 
within gene-rich regions, while LINEs and LTRs are 
under-represented [65]. Binding sites for several other 
transcription factors are proposed to be embedded in 
distinct families of retrotransposon elements [66–68]. 
We recently showed that embryonic stem cell (ESC) fac-
tors such as NANOG, SOX2 and OCT4 bind in LTR-
associated regulatory regions in ESC [69]. SINE Alu/B1 
elements contain bindings sites for transcription factors 
that are involved in cell development [70, 71]. Ours is the 
first report to our knowledge that identifies SINEs as car-
riers of Fox-binding sites (Fig. 4c, d).
VPA incubation has previously been shown to induce 
both histone acetylation and H3K4 methylation [72, 73]. 
In vivo FoxA1 binding has been demonstrated to corre-
late with H3K4 mono and dimethylation of enhancer ele-
ments [64]. This is consistent with our observation that 
Fox-binding sites become accessible after VPA treatment. 
While some Fox-binding sites demonstrate tissue speci-
ficity, a significant proportion of sites are suggested to be 
shared between different cell types [74]. The strong over-
lap between VPA-induced SINE DHSS in visual cortex 
and Foxa2-binding sites in mouse liver observed here may, 
therefore, be an underestimation of Fox binding in the 
induced sites. Different Fox members can also be acetylated 
at several sites [75]. Acetylation of FoxA1 has been sug-
gested to reduce its binding to DNA [76], while acetylation 
of FoxP3 has been shown to increase the affinity to DNA 
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and stabilize the Fox proteins [75]. Consequently, treatment 
with HDAC inhibitors may affect the affinity to DNA and 
protein stability of Fox proteins, in addition to increasing 
the accessibility of FOX-binding sites.
The nucleosome-free SINE elements may help to re-
program the genome organization in the nucleus. Tran-
scription factor TFIIIC complex binds to B-boxes and is 
proposed to form chromosome-organizing clamp (COC) 
in fission yeast [77]. TFIIIC loci tether distant loci to the 
nuclear periphery, without RNA polymerase binding, 
and are suggested to regulate genome organization [77]. 
Also, in budding yeast Pol III independent TFIIIC loci 
are detected [78], indicating that it may be a conserved 
phenomenon. Interestingly, Alu repeats contain B-box 
sequences and thus represent a large fraction of poten-
tial TFIIIC-binding sites that may play a role in genome 
organization. The large pool of Alu repeats that becomes 
available after VPA treatment (Fig. 4a; Additional file 1: 
Figure  S1e) may play an important role in re-program-
ming neurons and glial cells by nuclear reorganization. 
However, TFIIIC binding and COCs remain to be dem-
onstrated in VPA DHSSs. Repetitive elements not only 
serve as promoters, but may also be an important regula-
tor of nuclear structure. Retro-transposition has recently 
been suggested to contribute to neuronal plasticity with 
a prevalence of neuronal genes [70, 79]. Retro-transposi-
tion also takes place in ESCs and suggested to be impor-
tant for early development [80].
Expression of retrotransposon elements has been dem-
onstrated to be cell and tissue specific [81]. However, we 
could not detect enhanced transcriptional activation of 
SINEs implied by the increased accessibility to SINEs. In 
recent studies, it has been shown that RNA, expressed 
from retrotransposon elements is predominantly in the 
nuclear fraction and not in the cytosolic fraction [82]. 
Deep transcriptome profiling of mammalian stem cells 
supports a regulatory role for retrotransposons in pluri-
potency maintenance and that CAGE transcripts of long 
non-coding RNA are primarily detected in nuclear RNA 
libraries [82]. It may, therefore, be due to technical limita-
tions that we fail to detect transcription from the induced 
SINEs in our whole cell RNA libraries. Moreover, SINEs 
have been reported to be transcribed in the sense direc-
tion, by RNA polymerase III and do not get 5′-capped in 
this process [83, 84]. Therefore, it is possible that elevated 
SINE element transcription, if it occurs, could not be 
detected with CAGE in this study.
VPA induces global chromatin modification 
but brain‑specific gene expression
Different retrotransposon elements may function as 
regulatory elements in different tissues [66, 68, 69, 81, 
85, 86] and their roles are just starting to be deciphered. 
Recently, it was discovered that Alu insertions can func-
tion as gene promoters [51–53]. Interestingly, although 
many different types of retrotransposon elements are 
transcribed in a tissue [81], VPA induces availability 
specifically in SINEs. The distance between VPA DHSSs 
and expressed TSS clusters is usually from 10 kbp up to 
several Mbp long (Fig.  3f ), indicating that the induced 
DHSSs are not mainly involved in proximal regulation 
of transcription. The induced DHSSs may, therefore, be 
involved in distal gene regulation, repression, or regula-
tion of higher chromatin structure. This is in agreement 
with the majority of DHSSs previously being described 
as located distal from genes [20]. Indeed the induced 
DHSSs are enriched for enhancer regions. Incidentally, 
also other retrotransposon elements have been found to 
specifically act as cell-specific enhancers. In both human 
and mouse iPS and ESCs, a different class of retrotrans-
poson elements mostly constituted by ERVK and ERV1 
LTR elements has recently been found to produce cell-
type restricted enhancers [69]. These elements in iPS/
ESCs act as distal regulators involving transcription fac-
tors that are necessary for pluripotency. This finding rein-
forces the concept that specific retrotransposon elements 
can control specific cellular states or response, while fur-
ther studies in other system may further broaden the role 
of retrotransposon elements in gene regulation. In con-
trast, a subset of promoters that became activated after 
VPA treatment has proximal DHSSs in both treated and 
untreated visual cortex. These TSS clusters may repre-
sent genes that are poised for expression upon specific 
signaling.
We detected a high specificity in up-regulation of visual 
cortex-related genes, despite the dramatic genome-wide 
change in the epigenetic landscape after HDACi injec-
tion. It has previously been shown that treatment with 
HDACi activates only a subset of promoters [35, 87, 
88]. Thus, a seemingly unspecific drug results in a spe-
cific response. Genes primed with H3K4 trimethylation 
are suggested to be more easily acetylated, when treated 
with HDACi [35, 89], implying that genes may need to be 
poised for transcription to be activated by HDACi treat-
ment. Lopez-Atalaya et  al. have shown that the acetyla-
tion levels in hippocampus increase in gene bodies in 
active genes that are pre-marked with H3K4 trimeth-
ylation and H3K9/14 acetylation, and to some extent 
also regions distant (>10  kb) from any annotated gene, 
after TSA treatment [38]. These are the same genomic 
regions that were induced DHSSs located after VPA 
treatment (Fig. 1). In both our study and that of Lopez-
Atalaya et al. [32], the induced histone acetylation/DHSS 
and gene expression are uncoupled and a portion of the 
induced sites located in enhancers [38]. However, in both 
studies expression of HDACs is induced as a response 
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to treatment with HDACi (Fig.  3e). Among them is 
HDAC11, which has previous been shown to peak specif-
ically during the ocular dominance critical period in vis-
ual cortex [90]. The tissue specificity of the induced sites 
may then reflect the relative abundance of regulatory 
transcription factors in visual cortex and hippocampus, 
respectively, since in both cases the sites are enriched for 
specific transcription factor-binding sites (Fig. 4c–e) [38].
Several plasticity and chromatin regulatory genes 
became up-regulated through VPA treatment. However, 
the induced DHSS were mainly not located in promoter 
regions, but at a long distance from TSS clusters (Fig. 3f ). 
Cell-specific enhancer elements, identified by mapping 
p300 binding sites to the genome, have been shown to 
act at a very long distance from promoters [90]. Only a 
few percent of the p300 enhancers map within promoter 
regions and approximately 40–50 % lie 10–100 kbp away 
and 20–30  % further than 100  kbp distant from pro-
moters [90]. The enhancer distribution resembled the 
induced DHSS locations (Fig.  3f ), suggesting that the 
induced DHSS are enhancer regions. It has previously 
been shown that enhancers can function at >1 Mbp dis-
tant to their gene promoter target [91, 92]. Indeed both 
the non-induced and induced DHSS are significantly 
enriched for enhancer elements. Consequently, despite 
the distant location from TSS clusters, the induced DHSS 
may regulate the induced brain-specific gene expression.
Furthermore, the expression of Foxg1 is enhanced by 
VPA treatment (Additional file  5: Figure S2a, c). Foxg1 
acts mainly as a transcriptional repressor and interacts 
with the co-repressors Groucho family and HDAC1 [93]. 
Interestingly, Foxg1 interacting partners TLE/Grou-
cho were up-regulated in our CAGE VPA library (Addi-
tional file 3: Table S2). This finding indicates that Foxg1 
may play an important role in re-establishing a juvenile 
plastic state in visual cortex, as Foxg1 is implicated to 
be involved in neurogenesis and neuronal stem cell self-
renewal [94–96], radial versus horizontal cell migration 
[97] and suppresses early cortical cell fate [98]. Recently 
Foxg1 was suggested to cause a shift towards GABAeric 
neuron fate and alter the transcriptome network that is 
involved autism spectrum disorder [99]. Thus, further 
stress the importance of Foxg1 in the developing brain.
Notably, CP timing is exquisitely sensitive to the mat-
urational state of GABA neurons [1], suggesting that 
transcriptomic changes induced by VPA in adulthood 
is acutely recapitulating a juvenile form of excitatory–
inhibitory balance conducive to plasticity. The visual 
cortex is composed of many different cell types, both 
neurons and non-neurons, such as glia cells. It is likely 
that the different cell types will respond differently to the 
VPA treatment, making detailed analysis of a whole com-
plex tissue like the visual cortex challenging. With rapid 
developments in single-cell technologies, it may soon be 
possible to dissect the correlation, response to HDACi 
and role in plasticity, in a cell-specific manner.
Conclusions
We find that short-term VPA treatment causes a dra-
matic reorganization of chromatin structure: (a) genome-
wide formation of DHSS that overlap enhancer regions. 
(b) A genome-wide enhanced accessibility to repetitive 
elements, in particular SINE elements that overlap with 
putative Fox-binding sites. (c) Induction of specific gene 
transcription, including neuronal and epigenetic regula-
tory genes.
Methods
Animals
Adult C57BL/6J mice (>postnatal day P56) were main-
tained on a 12-h light/dark (LD) cycle and had access to 
food and water ad libitum.
Drug administration for plasticity analysis: Valproic 
acid (VPA; 200mgkg-1, i.p; Sigma-Aldrich) was dissolved 
in sterile saline. Vehicle or VPA was i.p. injected twice a 
day. Diazepam (DZ; 2 mg ml−1 in 50 % propylene glycol/
PBS, i.c.v; Sigma-Aldrich). Vehicle or DZ was injected 
daily into both lateral ventricles (1.5  μl per hemisphere 
and a total of 3 μl) for 2 days.
Monocular deprivation and drug administration: Prior 
to monocular deprivation (MD) experiments, VPA was 
injected into wild-type adult mice every 12 h for 2 days. 
After the 2nd day, eyelid margins were trimmed and 
sutured under halothane anesthesia for 4  days (brief 
MD). VPA was administered i.p. every 12 hourly over 
another 4  days. All recordings were obtained contralat-
eral to the deprived eye and blind to drug treatment.
Drug administration for DHSS and CAGE analysis: 
Valproic acid (VPA; 200 mg kg−1, i.p; Sigma-Aldrich) was 
dissolved in sterile saline. Equivalent volume of vehicle 
solution (Veh) was injected into control animals. Visual 
cortex was excised 2  h after Veh or VPA treatment for 
RNA extraction using RNAeasy kit (Qiagen) or for DHSS 
assay. All animal protocols were approved by the Institu-
tional Animal Care and Use Committee (IACUC) at the 
RIKEN Brain Science Institute, Japan.
Electrophysiology
Electrophysiological recordings were performed under 
Nembutal (50 mg kg−1; Abbot)/chlorprothixene (0.2 mg; 
Sigma) anesthesia using standard techniques [34].
HDAC activity
HDAC activity was measured using HDAC Fluorometric 
Assay/Drug Discovery kit (BIOMOL research Laborato-
ries Inc.), according to manufacturer’s instructions.
Page 12 of 15Lennartsson et al. Epigenetics & Chromatin  (2015) 8:55 
DHSS library production
Two visual cortices were resuspended in ice-cold resus-
pension buffer [50  mM Tris–HCL (pH 7.5), 0.8  M 
sucrose, 150 mMKCl, 5 mM Mg2Cl2]. The tissue was 
homogenized with a pellet pestle at the lowest speed for 
20 s. Cells were lysed by incubating on ice for 10 min with 
5 ml buffer A: 7.5 mM Tris–HCl (pH 7.4), 7.5 mM NaCl, 
2.5  mM MgCl2, 30  mM KCl, 0.05  mM EGTA, 0.5  mM 
DTT, 125  µM PMSF, 160  mM sucrose, 0.5  % NP40, 
0.5 mM spermidine and 0.1 M trehalose. The nuclei were 
washed in buffer A, without NP40, supplemented with 
20 % glycerol and 0.3 M sucrose and resuspended in 200 
μl buffer C: 10  mM Tris–HCl (pH 7.4), 15  mM NaCl, 
3 mM MgCl2, 0.6 mM CaCl2, 0.5 mM DTT and 0.25 M 
sucrose. The digestion was carried out at 22  °C with 2 
units DNase I for 15 min and RNase treated for 10 min 
at 37  °C. Addition of 200 μl stop buffer [100 mM NaCl, 
100 mM EDTA (pH 8.0), 1 % SDS, 50 mM Tris–HCl (pH 
8.0)] stopped the reaction. The digestion was controlled 
with Pulse Field electrophoresis.
After digestion, the sample was treated with proteinase 
K and DNA extracted with phenol/chloroform. The DNA 
was washed and purified on Microcon YM-30 columns. 
The DNase I digestion sites were mended with T4 DNA 
polymerase and 30  pmol biotinylated adaptor contain-
ing one Mme1 and one XbaI restriction site, was ligated 
to the mended cut sites. The unligated adaptors were 
removed using Microcon YM 100 column. The DNA 
was digested with MmeI and the adaptor-tag construct 
was purified with streptavidin-coated magnetic beads 
(Dynalbeads M280). While bound to the magnetic beads 
a second adaptor including an XbaI site was ligated to the 
constructs in ligation buffer supplemented with 0.5  M 
trehalose. After XbaI digestion, the DNA was ligated to 
Solexa bar-coded adaptors, amplified, purified on PAGE 
gels and sequenced on the Solexa platform.
DHSS tag mapping and clustering
73006924 sequenced and extracted tags were mapped 
to the mouse genome (mm9) using Nexalign (described 
in [100]) allowing for at most one mismatch. 63  % 
(26777479 VPA tags and 19241564 vehicle tags) mapped 
uniquely and were retained for further analysis.
The genome was scanned in windows of 10 kbp size, 
and each was further scanned in 500 bp windows. Con-
secutive 10 kb windows overlapped by 400 bp, and con-
secutive 500  bp windows overlapped by 100  bp. Given 
length L of the big window after correction for repeti-
tiveness (by considering the number of potential single 
mapping locations for 21-mers), the length l of the small 
window after the same correction, the number of tags 
N in the big window, the number of tags n in the small 
window, the expected number of tags E(n) and standard 
deviation σ were calculated using the binomial distribu-
tion with p = l/L. Simultaneously, in each small window, 
a random number nrand was drawn from the same distri-
bution, and E(nrand) and σrand were computed in the same 
way. This procedure was done separately for vehicle and 
VPA samples in each window. Subsequently, a combined 
normalized z score znorm =  (nnorm − E(nnorm))/σnorm was 
calculated, with nnorm  =  nveh  +  nVPA  ×  Ntot,veh/Ntot,VPA, 
E(nnorm)  =  E(nveh)  +  E(nVPA)  ×  Ntot,veh/Ntot,VPA, and 
σnorm = sqrt(σ2veh + σ2VPA × (Ntot,veh/Ntot,VPA)2). Ntot,veh and 
Ntot,VPA represent the total number of single mapping 
DHSS tags from the vehicle and VPA sample, respec-
tively. Similarly, a z score zrand was computed from nrand 
and σrand.
Finally, a cutoff zcutoff was chosen based on the distri-
butions of znorm and zrand, to give a 5  % false discovery 
rate (FDR). zcutoff =  5.5 fulfilled this criterion. Overlap-
ping clusters with znorm  ≥  zcutoff were merged, yielding 
9862 clusters retained for analysis. For each of the 9862 
clusters, a one-tailed Fisher’s exact test was performed to 
see whether it had a significantly greater amount of tags 
from the VPA condition. Clusters with FDR corrected p 
value (Benjamini-Hochberg) <0.05 were assigned as VPA 
induced.
Validation of DHSS with qPCR
Real-time PCR was performed as previously described 
[21, 37]. Nuclei isolation and DNase I treatment were 
performed as in DHSS library production protocol. 
Eight primer pairs in each of the following categories 
were designed to anneal: to VPA-induced DHSS at non-
TSS SINE DHSS, at TSS ± 2kbp or at random genomic 
sites. After DNase I digestion, amplicons could not 
be produced if the DNA region were open and avail-
able for DNase I digestion, which imply a higher Ct 
value than undigested DNA. Each PCR was performed 
in triplicate using DNA from VPA- or vehicle-treated 
visual cortex as template. One aliquot from each DNA 
sample was digested with DNase I and a corresponding 
aliquot was undigested. All qPCR were performed on 
7500 Real-time PCR System (Applied Bioscience) using 
an SyBR green assay. The ΔCt values  =  Ct (digested 
DNA) − Ct (undigested DNA). Statistical evaluation 
was performed with two-tailed t test, assuming une-
qual variance.
CAGE
CAGE was performed as previously described [30]. 
2287755 CAGE tags were sequenced, extracted and 
mapped to the mouse genome (mm9) using Nexalign 
allowing for at most two mismatches. 62 % (431797 VPA 
tags, 1042302 vehicle tags) mapped to unique locations 
and were subjected to clustering.
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Single linkage TSS clusters were constructed by merg-
ing overlapping CAGE tags as previously described [29, 
31]. 9828 clusters with at least 10 tags per million (TPM) 
in either or both samples were retained for further 
analysis.
Data availability
CAGE and DHSS sequencing data are available in DDBJ 
at the following accession number: DRA004104.
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